title: [Usefulness of the determination of 5NU together with CA 19-9 in the diagnosis and monitoring of dyskaryokinetic liver diseases].
authors.affiliation: Dipartimento Med. Sperimentale, Policlinico Umberto I, Roma.
authors.forename: D
authors.initials: D
authors.lastname: Santini
authors.forename: G G
authors.initials: GG
authors.lastname: Marchei
authors.forename: L
authors.initials: L
authors.lastname: Trasatti
authors.forename: M
authors.initials: M
authors.lastname: Di Seri
authors.forename: M G
authors.initials: MG
authors.lastname: Reale
authors.forename: I
authors.initials: I
authors.lastname: Frati
mesh_terms: D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D006801:Humans; D008107:Liver Diseases / Q000097:blood* / Q000473:pathology; D008113:Liver Neoplasms / Q000097:blood* / Q000473:pathology; D008938:Mitosis
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor
vernacular_title: Utilità del dosaggio del 5NU unitamente al CA 19-9 nella diagnostica e nel monitoraggio delle affezioni epatiche discariocinetiche.